(Q47930683)

16 June 2018

title

Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review (English)

1 reference

16 June 2018

bronchopulmonary dysplasia

main subject

1 reference

inferred from title

mesenchymal stem cell

1 reference

Angela Panoskaltsis-Mortari

inferred from title

author

series ordinal

3

object named as

Angela Panoskaltsis-Mortari

1 reference

16 June 2018

Ann A Simones

1

1 reference

16 June 2018

Daniel J Beisang

series ordinal

2

1 reference

16 June 2018

Kari D Roberts

series ordinal

4

1 reference

16 June 2018

language of work or name

English

0 references

publication date

25 October 2017

1 reference

16 June 2018

published in

Pediatric Research

1 reference

16 June 2018

volume

83

1 reference

16 June 2018

issue

1-2

1 reference

16 June 2018

page(s)

308-317

1 reference

16 June 2018

Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Mesenchymal Stem Cell-Derived Microvesicles Modulate Lipopolysaccharides-Induced Inflammatory Responses to Microglia Cells

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplant

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Lung mesenchymal stromal cells in development and disease: to serve and protect?

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Stem cell-based therapy for neonatal lung disease: it is in the juice

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Mesenchymal stem cells and the lung.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Mesenchymal stromal cells from neonatal tracheal aspirates demonstrate a pattern of lung-specific gene expression

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Isolation of tracheal aspirate mesenchymal stromal cells predicts bronchopulmonary dysplasia

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Wnt signaling controls the fate of mesenchymal stem cells

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Bronchopulmonary dysplasia

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895100

Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis.

14 August 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Modulating the stem cell niche for tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

7 January 2021

Extracellular Vesicles in Lung Disease

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

7 January 2021

PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic,

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

7 January 2021

Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

7 January 2021

Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.237

7 January 2021

Identifiers

DOI

10.1038/PR.2017.237

1 reference

16 June 2018

PMC publication ID

5895100

1 reference

16 June 2018

PubMed publication ID

28945702

1 reference

16 June 2018